Rapid, complete and sustained tumour response to the TRK inhibitor larotrectinib in an infant with recurrent, chemotherapy-refractory infantile fibrosarcoma carrying the characteristic ETV6-NTRK3 gene fusion
Titel:
Rapid, complete and sustained tumour response to the TRK inhibitor larotrectinib in an infant with recurrent, chemotherapy-refractory infantile fibrosarcoma carrying the characteristic ETV6-NTRK3 gene fusion
Auteur:
Bielack, S.S. Cox, M.C. Nathrath, M. Apel, K. Blattmann, C. Holl, T. Jenewein, R. Klenk, U. Klothaki, P. Müller-Abt, P. Ortega-Lawerenz, S. Reynolds, M. Scheer, M. Simon-Klingenstein, K. Stegmaier, S. Tupper, R. Vokuhl, C. von Kalle, T.